Shrijal S. Shah

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants”.

DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants

Journal of the American Society of Nephrology(2022)10.1681/asn.2021050723

N/A

0.553DataRank · unranked

39 citations

Cristian V. Riella, Hyunjae Chung, Shrijal S. Shah, Minxian Wang, Jose M. Magraner +7 more

Genetic risk factors for Mesoamerican nephropathy

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2404848121

N/A

0.416DataRank · unranked

15 citations

Dominick Leone, Juan José Amador, Joseph Kupferman, Lauren J. Francey, Damaris López-Pilarte +25 more

Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease

Disease Models & Mechanisms(2021)10.1242/dmm.048952

N/A

0DataRank · unranked

64 citations

Angelo Blasio, Olivia G Donovan, Lena B. Schaller, Althea Bock-Hughes, Jose M. Magraner +9 more